A registration statement relating to these securities has been filed with and declared effective by the Securities and Exchange Commission. The offerings may be made only by means of a prospectus supplement and the accompanying prospectus. Copies of the prospectus supplement and the accompanying prospectus may be obtained directly from the Company or by sending a request to Rodman & Renshaw. Application is being made to list 16,290,900 ordinary shares on the AIM and IEX, in respect of the above financings, respectively. Application is also being made to list 25,000,000 ordinary shares on AIM and IEX in respect of the consideration shares due to Ester. Admission is expected to occur on December 10, 2007.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the securities, nor shall there be any sale of these securities, in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities of each state.
Reverse Stock Split and Nasdaq Capital Market Listing Requirements
Amarin intends to send to its shareholders a notice of a General
Meeting at which Amarin will seek approval for a 1-for-10 reverse stock
split of the Company's ordinary shares. It is expected that the General
Meeting will take place in January 2008. Pursuant to Nasdaq Marketplace
Rule 4320(e)(2)(E)(ii), in order to maintain its listing on The Nasdaq
Capital Market, Amarin must maintain a minimum bid price of $1.00. In
affecting the 1-for-10 reverse stock split, Amarin expects the bid price of
its ADSs to greatly exceed the minimum bid p
|SOURCE Amarin Corporation Plc|
Copyright©2007 PR Newswire.
All rights reserved